Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

ACCRUED EXPENSES

ACCRUED EXPENSES

3 Months Ended

Mar. 31, 2022

ACCRUED EXPENSES

ACCRUED EXPENSES

NOTE 10. ACCRUED EXPENSES

Accrued expenses consisted of the following:


		March 31,			December 31,
($'s in thousands)		2022			2021
Accrued expenses:
Accrued compensation		$	4,421		$	2,702
Research and development			160			870
Accrued royalties payable			3,779			3,833
Accrued coupons and rebates			11,627			10,603
Return reserve			3,151			3,240
Other			2,747			1,485
Total accrued expenses		$	25,885		$	22,733